- Home
- ZIM vs VCEL Comparison
ZIM vs VCEL Comparison
Compare ZIM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIM
- VCEL
- Stock Information
- Founded
- ZIM 1945
- VCEL 1989
- Country
- ZIM Israel
- VCEL United States
- Employees
- ZIM N/A
- VCEL N/A
- Industry
- ZIM Marine Transportation
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZIM Consumer Discretionary
- VCEL Health Care
- Exchange
- ZIM Nasdaq
- VCEL Nasdaq
- Market Cap
- ZIM 2.0B
- VCEL 2.1B
- IPO Year
- ZIM 2021
- VCEL 1997
- Fundamental
- Price
- ZIM $15.49
- VCEL $36.24
- Analyst Decision
- ZIM Sell
- VCEL Strong Buy
- Analyst Count
- ZIM 4
- VCEL 7
- Target Price
- ZIM $14.70
- VCEL $61.29
- AVG Volume (30 Days)
- ZIM 3.5M
- VCEL 661.7K
- Earning Date
- ZIM 08-20-2025
- VCEL 07-31-2025
- Dividend Yield
- ZIM 46.06%
- VCEL N/A
- EPS Growth
- ZIM N/A
- VCEL 2045.40
- EPS
- ZIM 19.52
- VCEL 0.13
- Revenue
- ZIM $8,872,000,000.00
- VCEL $249,119,000.00
- Revenue This Year
- ZIM N/A
- VCEL $23.03
- Revenue Next Year
- ZIM N/A
- VCEL $24.51
- P/E Ratio
- ZIM $0.79
- VCEL $271.36
- Revenue Growth
- ZIM 65.83
- VCEL 16.13
- 52 Week Low
- ZIM $11.04
- VCEL $33.09
- 52 Week High
- ZIM $30.15
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ZIM 43.10
- VCEL 42.21
- Support Level
- ZIM $15.31
- VCEL $35.23
- Resistance Level
- ZIM $16.37
- VCEL $36.81
- Average True Range (ATR)
- ZIM 0.46
- VCEL 1.92
- MACD
- ZIM -0.02
- VCEL -0.15
- Stochastic Oscillator
- ZIM 12.89
- VCEL 36.25
About ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.